Arechar Healthcare reveals the launch of Lidmed (Lenalidomide) an effective medicine for the treatment of multiple myeloma (MM) and myelodysplastic syndrome (MDS). It belongs to the group of antineoplastic drugs known as immunomodulatory agents. It enhances the immune system that increases defense against the cancer cells. Lidmed inhibits the secretion of pro-inflammatory cytokines and increases the secretion of anti-inflammatory cytokines from peripheral blood mononuclear cells. The manufacturing team of Arechar Healthcare signifies the key point of Lidmed:-
Lidmed (Lenalidomide) is a thalidomide analog with potential antineoplastic activity. Lenalidomide inhibits TNF-alpha production, stimulates T cells, reduces serum levels of the cytokines vascular endothelial growth factor (VEGF) and basic fibroblast growth factor (bFGF), and inhibits angiogenesis.
Lidmed works by restricting the production of chemical messengers (cytokine and growth factor) which are responsible for the growth of cancer cells.
The molecular formula of Lenalidomide is C13H13N3O3 and the weight of the molecule is 259.26 g/mol.
This medication is available in the strength of 10mg and 25mg under the brand name Lidmed. It is a hard capsule and each capsule contains Lenalidomide as an active ingredient.
“Hope of cancer patients and their families need to be addressed. I strive to provide cancer medicines that will allow all cancer patients and their families to keep their hopes alive,” said Mr. Harpreet Singh, Founder of Arechar Healthcare.
“By launching the best regimen for the treatment of cancer, we, at Arechar Healthcare, promise to work with the same dedication and commitment, because this world needs more solutions and treatment options to maintain good accessibility and affordability of pharmaceutical products,” said Mrs. Ruchika Rajbans, Co-Founder of Arechar Healthcare.
About Arechar Healthcare
Arechar Healthcare is one of the largest leading manufacturers of life-saving drugs, working to serve the patients with the best and approved life-saving drugs at an affordable range of prices. It has attained an authoritative position worldwide in the field of Pharma. It has successfully extended its reach globally and is working with immense insight into humanity. Very few
Related hot topics
Bortecine, an effective drug for Blood cancer
Bortecine, for Multiple Myeloma and Mantle Cell Lymphoma
Arechar Healthcare provides independent and precise information about prescription drugs with the related news and press releases. This content is displayed for informational purposes only and is not intended to be an alternative for any medical advice/prescription or treatment. Do not delay or ignore any medical treatment owing to something you’ve read or seen on this website. Also, this website offers links to other websites, enabling the viewers to directly switch to that website for detailed information or accurate references. Thus, Arechar is not responsible for the content displayed on the linked websites or the content of the links in the linked website.